← Eichor
Study identifier: NCT06555952 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Condition: Hypertension · Pre Diabetes  ·  Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology

PhaseNA
Planned participants80
Who can joinAll sexes, 40 Years to 60 Years
Healthy volunteersNo

About this study

Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation.

This description comes directly from the study's public registry record.

Talk to the study team

Indika Edirisinghe  ·  708-563-8178  ·  iedirisi@iit.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Clinical Nutrition Research CenterChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06555952